(Know more about our events and news.)
The product is intended to be in the hands of the Oncologists and clinicians who may want to validate the optimal plan from many alternative treatment plans to take cancer patient survival probability beyond the assessed length of life. This is all made possible by predicting and prescriptive analytics of data science. In other words a tool in the hands of the Oncologist to take data-driven decision to cross validate prescribed treatment plan.
There are two facets of this unique product: